INVITATION

LCZ696 PARADIGM-HF trial update

We would like to invite you to a live meeting and audiocast following the presentation at ESC 2014 of the PARADIGM-HF trial results of LCZ696 in chronic heart failure.
This event will be hosted by David Epstein, Head Novartis Pharmaceuticals.

When :	Sunday, August 31, 2014 - 17.00 h CEST
Venue :	Hotel Porta Fira (across Congress Center main entrance) Plaza Europa, 45-47, 08908 Hospitalet de Llobregat, Barcelona, Spain Meeting room: Santemar
Dial-in :	Local - UK / International	+44(0)20 3427 1913
	Local - Germany	+49(0)69 2222 10619
	Local - Switzerland	+41(0)22 567 5431
	Local - France	+33(0)1 76 77 22 31
	Toll free phone - USA	+1 877 280 1254
	Participant Passcode	6803006

Please note that during the Q&A session, we will give priority to questions from participants in the meeting room at the ESC.
If time permits we will also take questions via email. Please send these to isabella.zinck@novartis.com.

With kind regards

Investor Relations

Novartis Global Investor Relations / General phone: +41 61 324 79 44
Samir Shah / Global Head Investor Relations +41 61 324 79 44

Basel Office		North America Office
Pierre-Michel Bringer Thomas Hungerbuehler Isabella Zinck	+41 61 324 10 65 +41 61 324 84 25 +41 61 324 71 88	Stephen Rubino Susan Donofrio	+1 862 778 83 01 +1 862 778 92 57

e-mail: investor.relations@novartis.com |www.novartis.com

INVITATION - LCZ696 PARADIGM-HF trial update

INVITATION